Abstract
Novel Drug Delivery System (NDDS) is a novel approach to deliver the drug that addresses the limitations of the traditional drug delivery systems with enhanced patient care and site specific drug delivery. Besides several NDDS are currently used for treating Coronavirus disease (COVID-19), nanovaccines, liposomes and nanoparticles are gaining more interest towards research and manufacturing in pharmaceutical industry. COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. It has found its roots from China and has declared as a pandemic all over the world by World Health Organization (WHO). Till now, there is no ultimate cure for this outbreak. The recent developments in the domain of NDDS opened up numerous research exposures in the development of vaccines for the COVID-19. This review discusses the management of COVID-19 using NDDS like nanovaccines, the repurposing of the existing drugs using nanosystems, and the major market players of NDDS.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
